MacDonald Sean Arthur 4

What Happened Sean Arthur MacDonald, a director of Edesa Biotech, Inc. (EDSA), received a grant of 19,000 restricted share units (RSUs) on 2026-05-27. The RSUs were reported at $0.00 per share (no cash purchase) — total reported acquisition value $0 — and are classified as an award/grant (A) on the Form 4.

Key Details

• Transaction date: 2026-05-27; Form 4 filed: 2026-05-29 (appears timely).
• Security: Restricted share units representing 19,000 shares; reported price: $0.00; total reported value: $0.
• Vesting: Per footnote, the RSUs vest in equal proportions over 12 months beginning on the grant date.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Transaction type code: A = Award/Grant/Other acquisition.
• No 10b5-1 plan, tax‑withholding, or sale noted in this filing.

Context This was a compensation award (RSUs) to a director rather than an open‑market purchase or sale. Such grants are common as part of director compensation and do not by themselves indicate buying/selling sentiment. The award vests over the next year, so the economic interest in underlying shares will accrue gradually as vesting occurs.